Juul fails to properly report clinical trial results

Drug and medical device companies have a long history of selective reporting the results of clinical trials used to test their new products and even of burying results they don’t like. In an effort to make it harder for companies to manipulate reporting of results, the federal government (NIH) created ClinicalTrials.gov, where companies and othersContinue reading “Juul fails to properly report clinical trial results”

More details on how menthol helps Big Tobacco keep kids hooked

Keeping menthol in cigarettes (and other tobacco products) has been a priority for the tobacco companies ever since they got it exempted from the characterizing flavor ban in the 2009 Family Smoking Prevention and Tobacco Control Act that gave the FDA jurisdiction over tobacco products. The already-strong case for banning menthol just got stronger withContinue reading “More details on how menthol helps Big Tobacco keep kids hooked”

More direct evidence that SF flavor ban worked

Last year we published a paper on implementation of San Francisco’s ban on the sale of flavored tobacco products (including menthol) that reported that health department inspectors found high compliance with the flavor ban when they visited retailers. Now, Doris Gammon and colleagues have shown that the law virtually eliminated sales of flavored tobacco productsContinue reading “More direct evidence that SF flavor ban worked”

We know a lot about how e-cigarettes cause disease

The evidence on the health effects of e-cigarettes was the subject of two recently published reviews that focus on cardiovascular, pulmonary and immunologic effects of e-cigarettes. These reviews complement earlier reviews on the pulmonary effects of e-cigarettes, e-cigarettes and smoking cessation, and the gateway effect for smoking among youth and young adults. Taken together theseContinue reading “We know a lot about how e-cigarettes cause disease”

Growing international consensus (except UK) on dangers of e-cigs

Recently, Cynthia Callard of Physicians for a Smokefree Canada posted a blog commenting on three reports on vaping issued last week by the European Union, the WHO and the UK Royal College of Physicians. The EU and WHO reports reflect in part a growing consensus that: There are harms from e-cigarettes, especially harms to theContinue reading “Growing international consensus (except UK) on dangers of e-cigs”

What we can and cannot say about the immediate effect of SF’s flavored tobacco product ban

On May 24, 2021 Abigail Friedman published “A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California” in JAMA Pediatrics that concluded that “San Francisco’s ban on flavored tobacco product sales was associated with increased smoking among minor high school students relative to other school districts.”Continue reading “What we can and cannot say about the immediate effect of SF’s flavored tobacco product ban”

Can you believe the papers in the AJHB issue Juul financed?

When I wrote “Surprise! Juul publishes a paper concluding that e-cigs save lives” criticizing a paper in American Journal of Health Behavior for being based on questionable risk estimates, my first draft said I was surprised that the paper got past independent peer reviewers. But then I realized that all but one of the 13 papersContinue reading “Can you believe the papers in the AJHB issue Juul financed?”

CDC’s new mask guidance and why FDA CTP should not assume e-cigs help smokers quit in the real world

On May 13, 2021 the CDC lifted most restrictions on the use of masks for people fully vaccinated against COVID-19 (two weeks after the second shot for Pfizer or Moderna and 1 week after J&J). While some people thought this was a political decision, CDC Director Walensky explained in detail that real world experience showedContinue reading “CDC’s new mask guidance and why FDA CTP should not assume e-cigs help smokers quit in the real world”

Ecigs double risk of relapse among former smokers

Most of the discussion of the effects of e-cigarette use on smoking has focused on their gateway effect among youth (they are) and whether e-cigs help smokers quit (as consumer products they do not) . There has been much less attention to how e-cigarettes affect the risk of relapse among former smokers. But now thereContinue reading “Ecigs double risk of relapse among former smokers”

Federal court adding RICO claims to lawsuits against Juul opens up opportunity to inform the public and FDA

On April 13, 2021, federal judge William H. Orrick granted plaintiffs’ motion to add allegations that Altria (owner of Philip Morris and part of Juul) and the Founder and Director Defendants violated the federal Racketeer Influenced and Corrupt Organizations Act (“RICO”). Specifically, Judge Orrick allowed allegations that the “company and those persons allegedly conducted actsContinue reading “Federal court adding RICO claims to lawsuits against Juul opens up opportunity to inform the public and FDA”